Description
AOD9604 supplied as a research reagent for in-vitro laboratory use. Every lot is assayed by reverse-phase HPLC to ≥98% purity, with identity confirmed by mass spectrometry and residual water content checked by Karl Fischer titration. Purity is verified across multiple independent laboratories, and material is sourced across multiple manufacturers so the highest-purity batch can be selected for release.
Specification
- CAS number: 221231-10-3
- Physical form: Lyophilised powder
- Purity: ≥98% by RP-HPLC
- Storage: 2°C – 8°C, protect from light
Research findings
- A modified C-terminal fragment of human growth hormone, characterised in preclinical work as reproducing the lipolytic domain of the parent hormone without the growth-promoting or insulin-related activity of full-length GH [1, 2]
- Preclinical metabolic studies of the synthetic lipolytic domain [1]
- Effects on lipid metabolism following chronic treatment examined in preclinical models [2]
Regulatory status
RESEARCH USE ONLY — NOT FOR HUMAN CONSUMPTION. Supplied strictly for in-vitro laboratory research by qualified professionals. Not a medicine, supplement, cosmetic or food. Must not be administered to humans or animals.
Vial and carton labels show 99% purity — the specification we aim for on every batch. Our guaranteed minimum is ≥98% by RP-HPLC, and the measured result for each batch appears on its certificate of analysis.
Reviews
There are no reviews yet.